Login

Journal Image
Current Drug Target -CNS & Neurological Disorders
ISSN (Print): 1568-007X
ISSN (Online): 1568-007X
VOLUME: 4
ISSUE: 4
DOI: 10.2174/1568007054546072      Price:  $58









Neurodegenerative Pathways in Parkinsons Disease: Therapeutic Strategies

img
Author(s): S. M. Cardoso, P. I. Moreira, P. Agostinho, C. Pereira and C. R. Oliveira
Pages 405-419 (15)
Abstract:
Parkinsons disease (PD), considered one of the major neurological disorders, is characterized by the loss of dopaminergic neurons in the pars compacta of the substantia nigra and by the presence of intraneuronal cytoplasmic inclusions called Lewy bodies. The causes for degeneration of PD neurons remain unclear, however, recent findings contributed to clarify this issue. This review will discuss the current understanding of the mechanisms underlying Parkinsons disease pathogenesis, focusing on the current and potential therapeutic strategies for human treatment.
Keywords:
synuclein, neuronal circuits, oxidative stress, mitochondria, proteasome, neuroinflammation, cell death, therapeutics
Affiliation:
Center for Neuroscience and Cell Biology and Institute of Biochemistry, Faculty of Medicine ofCoimbra, University of Coimbra, 3004-504 Coimbra, Portugal;